| Literature DB >> 35616425 |
Chunxiao Sun1, Qianwen Liu1, Mudassir Shah1, Qian Che1, Guojian Zhang1,2,3, Tianjiao Zhu1, Jianfeng Zhou1,2, Xiaozhi Rong1,2, Dehai Li1,2.
Abstract
The Wnt/β-catenin signaling pathway is an evolutionarily conserved signaling cascade involved in a broad range of biological roles. Dysregulation of the Wnt/β-catenin pathway is implicated in congenital malformations and various kinds of cancers. We discovered a novel Wnt/β-catenin inhibitor, talaverrucin A (1), featuring an unprecedented 6/6/6/5/5/5/6 fused ring system, from an Antarctica sponge-derived fungus Talaromyces sp. HDN151403. Talaverrucin A exhibits inhibitory activity on the Wnt/β-catenin pathway in both zebrafish embryos in vivo and cultured mammalian cells in vitro, providing a naturally inspired small molecule therapeutic lead to target the Wnt/β-catenin pathway.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35616425 DOI: 10.1021/acs.orglett.2c01394
Source DB: PubMed Journal: Org Lett ISSN: 1523-7052 Impact factor: 6.005